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Abstract
People living with AIDS are at increased risk of developing certain cancers. Since the introduction of the highly active
antiretroviral therapy (HAART), the incidence of AIDS-defining cancers (ADCs) has decreased in high-income countries.
The objective of this study was to analyse trends in ADCs and non-AIDS-defining cancers (NADCs) in HIV-positive
people with a diagnosis of AIDS, in comparison to the general population, in São Paulo, Brazil. A probabilistic record
linkage between the ‘Population-based Cancer Registry of São Paulo’ and the AIDS notification database (SINAN) was
conducted. Cancer trends were assessed by annual per cent change (APC). In people with AIDS, 2074 cancers were
diagnosed. Among men with AIDS, the most frequent cancer was Kaposi’s sarcoma (469; 31.1%), followed by non-
Hodgkin lymphoma (NHL; 304; 20.1%). A decline was seen for ADCs (APC¼14.1%). All NADCs have increased
(APC¼ 7.4%/year) significantly since the mid-2000s driven by the significant upward trends of anal (APC¼ 24.6%/year)
and lung cancers (APC¼ 15.9%/year). In contrast, in men from the general population, decreasing trends were observed
for these cancers. For women with AIDS, the most frequent cancer was cervical (114; 20.2%), followed by NHL (96;
17.0%). Significant declining trends were seen for both ADCs (APC¼15.6%/year) and all NADCs (APC¼15.8%/
year), a comparable pattern to that found for the general female population. Trends in cancers among people with AIDS
in São Paulo showed similar patterns to those found in developed countries. Although ADCs have significantly decreased,
probably due to the introduction of HAART, NADCs in men have shown an opposite upward trend.
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Introduction
Several studies have shown an increased risk for cancer
among people living with HIV/AIDS (PLWHA);
however, the risks have changed over time. Since the intro-
duction of the highly active antiretroviral therapy
(HAART), some countries have documented significant
declines in AIDS-defining cancers (ADCs), namely
Kaposi’s sarcoma (KS), non-Hodgkin lymphoma
(NHL) and cervical cancer (CC). In contrast to this,
increasing trends in non-AIDS-defining cancers
(NADCs) were found in many recent studies.1–5 Most of
the studies assessing cancer burden in PLWHA have been
conducted in developed countries, such as the United
States (US), Spain and Italy, where population-based
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cancer and AIDS registries coexist. Unfortunately, in
many countries, both at high- and or middle-income
levels, such studies are not feasible, due to the lack of
population-based registries, or due to the inability of con-
ducting record linkage because of anonymized records,
poor database quality or intermittent data collection,
among other constraints.
In Brazil, AIDS notification became mandatory in
1986 and cases diagnosed before that time were rec-
orded retrospectively. The state of São Paulo has
played a crucial role in the AIDS epidemic, having
launched the first AIDS programme in the country,
providing treatment free of cost.6 São Paulo city has
the highest percentage (12.6%) of all AIDS cases diag-
nosed nationally.7 The city also has a population-based
cancer registry, which covers the largest population in
Brazil, and has uninterruptedly collected data on cancer
incidence since 1997.
The present study analysed the trends in incidence
of cancers in residents of São Paulo with HIV between
1997 and 2012, in comparison to the general population.
Methods
A total of 87,109 AIDS cases were diagnosed in HIV-
positive persons aged 13 years in São Paulo from 1980
to 2013.8 Between 1997 and 2012, the ‘Population-based
Cancer Registry of São Paulo’ (PBCR-SP) registered
628,161 cancers (496,276 invasive) among São Paulo
residents.
A probabilistic record linkage was conducted between
the PBCR-SP (1997–2012) and the AIDS notification
database SINAN (Sistema de Informações de Agravos
de Notificação/Information System on Disease
Notification) (1980–2013) containing AIDS cases. The
Brazilian Ministry of Health preferably uses the AIDS
case definition of the Centers for Disease Control and
Prevention and alternatively the definition of Rio de
Janeiro/Caracas.9 Both registries cover the same terri-
tory: the city of São Paulo, which according to the
2010 census, comprises an area of 1521 km2 and is
home to 11,253,503 inhabitants (99.1% urban), corres-
ponding to almost 6% of the Brazilian population. Its
current human development index is 0.805.10
A probabilistic record linkage was conducted, in a
multi-step process, using different blocking strategies.
Soundex, which is the phonetic algorithm for indexing
names by sound, was used in place of names for block-
ing. The blocking strategies contained a combination of
soundex of the first name, soundex of the last name,
decade of birth and sex. Full name and date of birth
were used for calculating the weighted scores. Clerical
review based on name, date of birth, mother’s name
and address, when available, was carried out in all
steps to improve record linkage sensitivity. This process
was conducted using the open source software
OpenRecLink (version 2.9). After the identification of
true matches, patients were excluded from the analysis
if they had a cancer diagnosis 60 months or more prior
to their AIDS diagnosis.
Cancers were grouped into two major categories:
ADCs (KS, NHL and CC) and NADCs (all other can-
cers). The annual AIDS population according to
gender and age group was estimated as the difference
between cumulative cases and cumulative deaths per
year.
The crude incidence rates were calculated according to
gender, dividing the number of incident cases by the esti-
mated AIDS population in a given year and presented as
rates per 100,000 persons. Crude rates were also calcu-
lated according to the following age groups: 20–29, 30–39,
40–49, 50–59, 60–69 years. As for the general population,
the denominator for rates was the resident population
of São Paulo, as provided by the Brazilian Institute
of Geography and Statistics.10 Age-standardized rates
(ASRs) by sex were calculated using the direct method
based on the world population, as proposed by SEGI and
modified by Doll and Waterhouse.11
In the descriptive analyses, persons with multiple
cancer diagnoses were only included once (considering
the first cancer). To assess trends in ADCs, NADCs
and most incident cancers (anal, colorectal and lung
cancers in men; breast and colorectal cancers in
women) in the population with AIDS, the three-year
moving average of the ASR was calculated.
Subsequently, the annual per cent change (APC) was
estimated, as follows: APC ¼ ½exp year
 
 1  100,
and its respective 95% confidence intervals with expo-
nentially transformed values using the Joinpoint soft-
ware (version 4.2.0.2). Data from the PBCR-SP were
analysed to assess trends in cancer incidence in the gen-
eral population. The series of the PBCR-SP started in
1997. Since its trends are greatly affected by the AIDS
epidemic, no specific trend analysis for the general
population was conducted for KS.
To compare risk for cancer within age groups, the
ratio between crude age-specific rates of the oldest age
group (60–69 years) and the youngest (20–29 years) was
calculated. All statistical analyses were stratified by sex.
This research obtained ethical clearance from the
Ethics Review Board at the School Public Health,
University of São Paulo (686.849), from the Municipal
Health Secretariat of São Paulo (703.467) and from the
University of Munich (233.15). After record linkage, the
database was anonymized to ensure data privacy.
Results
Table 1 displays the main characteristics of all AIDS
cases registered in São Paulo from 1980 to 2013.
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The majority of cases were men (72.8%), aged 20–49
years (88.5%) at AIDS diagnosis. The estimated
number of persons living with AIDS increased substan-
tially from 13,895 (of which 76.1% are males) in 1997
to 44,741 (of which 69.0% are males) in 2012. Young
males (20–49 years) accounted for over 60% of the
AIDS population at risk of cancer (data not shown).
Of all 496,276 invasive cancers diagnosed between
1997 and 2012, 2074 cancers occurred in 2000 persons
with AIDS. Seventy-four persons were diagnosed with
two primary site tumours, thus, the descriptive statistics
shown in Table 2 was based on 2000 persons. The
majority were male (1461; 73.0%), white (1111;
55.6%) and aged 30–49 years old at cancer diagnosis
(1257; 62.9%). Heterosexual (674; 33.7%) and homo-
sexual (447; 22.4%) practices were the most frequent
stated categories of exposure to HIV.
Table 3 presents the number of cases and trend ana-
lyses of ADCs, NADCs, and most incident cancers in
men and women both with AIDS and from the general
population; in these analyses all 2074 cancers were con-
sidered. Most cancers (51.0%; 1057 out of 2074
cancers) in the AIDS population were classified as
NADCs, corresponding to 56.7% cancers in women
(n¼ 320). In men, ADCs were slightly more frequent
than NADCs, representing 51.2% (n¼ 773) of all 1510
male cases. The five most incident cancers among men
with AIDS were KS (469; 31.1%), NHL (304; 20.1%),
anal cancer (63; 4.2%), colorectal cancer (59; 3.9%) and
lung cancer (54, 3.6%). In the general male popula-
tion, the most frequent cancer sites were prostate
(23.4%), colon and rectum (9.5%), lung (7.2%), stomach
(6.5%) and skin non-melanoma (6.1%) (data not shown).
In women with AIDS, CC (114; 20.2%), NHL
(96; 17.0%), breast cancer (72; 12.8%), KS (34; 6.0%)
and colorectal cancer (19; 3.4%) were the most incident
cancers. In contrast, among women from the general
population, breast (25.6%), colon and rectum (8.9%),
Table 1. Socio-demographic characteristics of people diagnosed with AIDS, according to
gender. São Paulo, 1980–2013.
Total Male Female
n % n % n %
Race/ethnicity
White 21,935 25.2 15,360 24.2 6575 27.8
Black 4292 4.9 2715 4.3 1577 6.7
Asian 303 0.3 214 0.3 89 0.4
Pardoa 10,079 11.6 6484 10.2 3595 15.2
Indigenous 64 0.1 48 0.1 16 0.1
Unknown 50,436 57.9 38,616 60.9 11,820 49.9
Age at AIDS diagnosis (years)
13–19 1453 1.7 963 1.5 490 2.1
20–29 22,818 26.2 16,044 25.3 6774 28.6
30–39 34,892 40.1 26,132 41.2 8760 37.0
40–49 18,944 21.7 13,964 22.0 4980 21.0
50–59 6548 7.5 4621 7.3 1927 8.1
60–69 1853 2.1 1258 2.0 595 2.5
70 423 0.5 311 0.5 112 0.5
Unknown 178 0.2 144 0.2 34 0.1
HIV exposure category
Homosexual men 17,589 20.2 17,589 27.7 NA NA
Bisexual 6001 6.9 5977 9.4 24 0.1
Heterosexual 31,550 36.2 14,832 23.4 16,718 70.6
Intravenous drug user 13,643 15.7 11,256 17.7 2387 10.1
Other 595 0.7 402 0.6 193 0.8
Unknown 17,731 20.4 13,381 21.1 4350 18.4
Total 87,109 100 63,437 100 23,672 100
NA: not applicable.
aPardo refers to multiracial persons of African ancestry.
Source: Epidemiological surveillance on STDs/AIDS, Municipal Department of Health, São Paulo, Brazil.
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thyroid (7.5%), cervix (5.2%) and skin non-melanoma
(5.2%) were the most frequent cancer sites (data not
shown).
As for the trend analyses in men with AIDS, a statis-
tically significant decline was seen in general for ADCs
(APC¼14.1%/year), but also in particular for KS
(APC¼16.2%/year) and NHL (APC¼11.9%/year).
In contrast to this, all NADCs decreased (APC¼
9.7%/year) until the mid-2000s, when it started
to increase (APC¼ 7.4%/year). Incidence of anal and
lung cancer have significantly increased by 24.6
and 15.9%, respectively, whereas colorectal cancer
remained stable. In the general male population, NHL,
colorectal, lung and anal cancers had significant declines
in incidence of 2.8, 1.3, 7.6, 5.9%/year, respect-
ively (Figure 1(a) to (d)).
Among women with AIDS, a statistically significant
decline was seen in general for ADCs (APC¼15.6%/
year), and in particular for KS (APC¼26.7%/year),
NHL (APC¼15.8%/year), CC (APC¼12.8%/
year) and breast cancer (APC¼10.1%/year) in par-
ticular. In contrast to this, the incidence of colorectal
cancer remained stable. Additionally, also for all
NADCs (APC¼15.8%/year), the decline was signifi-
cant. Declining trends in all cancers analysed were
found for women from the general population.
Table 2. Socio-demographic characteristics of 2000 people with AIDS and cancer, according
to gender. São Paulo, 1997–2012.
Total Male Female
n % n % n %
Race/ethnicity
White 1111 55.6 860 58.9 251 46.6
Black 143 7.2 84 5.7 59 10.9
Asian 14 0.7 10 0.7 4 0.7
Pardoa 255 12.8 159 10.9 96 17.8
Unknown 477 23.9 348 23.8 129 23.9
Age at AIDS diagnosis (years)
13–19 16 0.8 9 0.6 7 1.3
20–29 348 17.4 241 16.5 107 19.9
30–39 733 36.7 534 36.6 199 36.9
40–49 528 26.4 397 27.2 131 24.3
50–59 277 13.9 210 14.4 67 12.4
60–69 82 4.1 55 3.8 27 5.0
70 16 0.8 15 1.0 1 0.2
Age at cancer diagnosis (years)
13–19 8 0.4 6 0.4 2 0.4
20–29 225 11.3 163 11.2 62 11.5
30–39 650 32.5 467 32.0 183 34.0
40–49 607 30.4 438 30.0 169 31.4
50–59 348 17.4 271 18.5 77 14.3
60–69 135 6.8 95 6.5 40 7.4
70 27 1.4 21 1.4 6 1.1
HIV exposure category
Homosexual men 447 22.4 447 30.6 NA NA
Bisexual 179 9.0 179 12.3 – –
Heterosexual 674 33.7 313 21.4 361 67.0
Intravenous drug user 145 7.3 105 7.2 40 7.4
Other 10 0.5 4 0.3 6 1.1
Unknown 545 27.3 413 28.3 132 24.5
Total 2000 100 1461 100 539 100
NA: not applicable.
aPardo refers to multiracial persons of African ancestry.
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The analysis of crude rates stratified by age group
revealed that the risk for all ADCs (KS, NHL and CC)
increased with age (Figure 2(a) and (b)). Risk for all
NADCs among persons with AIDS was 38.3-fold in
men and 35.6-fold in women, when comparing the oldest
(60–69 years) to the youngest age group (20–29 years).
Discussion
This is the first study in Brazil estimating the incidence
of cancer in patients with AIDS at a population level.
Our results reveal a high and changing cancer burden in
this population, as found in similar studies conducted
in North America and Europe, as well as a multicentre
cohort study performed in Rio de Janeiro (Brazil) and
Nashville (US).2,4,5,12,13
Although approximately half of cancers identified in
our study were classified as ADCs, their incidences have
dramatically declined in São Paulo, but remain at high
rates when compared to the general population.
Declining trends in ADCs have been documented in sev-
eral studies, with one of themost probable contributors to
this being the introduction of HAART in 1996.2,5
Treatment with HAART, if timely, alters the course of
HIV infection by preventing or reversing profound
immunosuppression, and thereby, decreasing susceptibil-
ity of developing AIDS-defining illnesses, including
ADCs.14,15 Despite efforts to scale up HIV testing and
early diagnosis, late entries to HIV care are still very fre-
quent worldwide and could prevent further reduction in
ADCs burden.16,17 A study conducted in Brazil revealed
that between 2003 and 2006, 43.6% of persons aged 15
and older diagnosed with AIDS entered HIV care late,
either having CD4þ cell counts 200 cells/mm3, an
AIDS-defining illness at the initial examination or
having died within the first 20 days of entry.18 In these
cases, delayed introduction of HAART could be less
effective in improving the immune system and its ability
to control oncogenic viruses, such as Epstein–Barr virus
(risk factor for NHL) and human herpes virus 8 (asso-
ciated with KS), increasing the overall risk for ADCs.
On the other hand, since 2013, the Brazilian
Ministry of Health encourages the immediate initiation
of antiretroviral therapy among all individuals diag-
nosed with HIV infection, regardless of CD4þ cell
counts.19 This measure could lead to further declines
in ADCs, by preventing persons diagnosed with HIV
only from developing AIDS and its defining illnesses.
Steep reduction (APC¼15.8% in women; 11.9%
in men) in NHL in the AIDS population could have
Table 3. Trends in 2074 cancer cases found among 2000 people with AIDS and cancer and people from general population,
according to sex. São Paulo, 1997–2012.
Persons with AIDS General population
n APC 95% CI p n APC 95% CI p
Malea
All AIDS-defining cancers 773 14.1 16.6; 11.6 <0.01 NA NA NA NA
Kaposi sarcoma 469 16.2 18.8; 13.4 <0.01 NA NA NA NA
Non-Hodgkin lymphoma 304 11.9 15.5; 8.2 <0.01 7719 2.8 3.5; 2.1 <0.01
All non-AIDS-defining cancers (1997–2005)b 361 9.7 12.2; 7.1 <0.01 NA NA NA NA
All non-AIDS-defining cancers (2005–2012) 376 7.4 3.6; 11.4 <0.01 NA NA NA NA
Anal cancerc 63 24.6 16.0; 33.9 <0.01 616 5.9 10.1; 1.5 <0.01
Colorectal cancer 59 3.9 11.5; 4.3 0.30 22,565 1.3 2.1; 0.5 <0.01
Lung cancer 54 15.9 6.9; 25.7 <0.01 17,082 7.6 8.3; 6.9 <0.01
Femaled
All AIDS-defining cancers 244 15.6 18.8; 12.3 <0.01 NA NA NA NA
Cervical cancer 114 12.8 16.3; 9.2 <0.01 14,765 8.2 9.1; 7.3 <0.01
Non-Hodgkin lymphoma 96 15.8 20.0; 11.4 <0.01 7220 2.4 3.0; 1.7 <0.01
Kaposi sarcoma 34 26.7 34.7; 17.7 <0.01 NA NA NA NA
All non-AIDS-defining cancers 320 15.8 20.0; 11.3 <0.01 NA NA NA NA
Breast cancer 72 10.1 19.1; 0.2 <0.01 72,134 1.8 2.5; 1.1 <0.01
Colorectal cancer 19 1.9 10.3; 15.8 0.70 24,975 1.5 2.3; 0.7 <0.01
APC: annual per cent change; CI: confidence interval; NA: not applicable.
aCancer cases add up to 1510 in men with AIDS.
bSegment provided by Joinpoint.
c2002 onwards.
dCancer cases add up to 564 in the women with AIDS.
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Figure 1. (a) Age standardized incidence rates of AIDS-defining and non-AIDS-defining cancers in the AIDS population according to
gender. São Paulo, 1997–2012. Rates are presented based on three-year moving average and displayed on a logarithmic scale. (b) Age
standardized incidence rates of Kaposi’s sarcoma in the AIDS population according to gender. São Paulo, 1997–2012. Rates are
presented based on three-year moving average. (c) Age standardized incidence rates of non-Hodgkin lymphoma in the AIDS popu-
lation and in the general population according to gender. São Paulo, 1997–2012. Rates are presented based on three-year moving
average and displayed on a logarithmic scale. (d) Age standardized incidence rates of cervical cancer in the AIDS population and in the
general population. São Paulo, 1997–2012. Rates are presented based on three-year moving average and displayed on a logarithmic
scale.
Figure 2. (a) Crude incidence rates for AIDS-defining cancers, non-AIDS-defining cancers, Kaposi’s sarcoma and non-Hodgkin
lymphoma in men with AIDS according to age group. Sao Paulo, 1997–2012. Rates are displayed on a logarithmic scale. (b) Crude
incidence rates for AIDS-defining cancers, non-AIDS-defining cancers, Kaposi’s sarcoma, non-Hodgkin lymphoma and cervical cancer
in women with AIDS according to age group. Sao Paulo, 1997–2012. Rates are displayed on a logarithmic scale.
Tanaka et al. 1195
contributed to declining trends at the general popula-
tion level (APC¼2.4% in women; 2.8% in men),
as they account for 4% of all cases. Similar declining
patterns for CC were identified in women with AIDS
and women from the general population. In both cases,
the propagation of Pap smear screening may have con-
tributed to this epidemiological pattern as the test can
identify cervical lesions before they evolve to CC.
In São Paulo, over 90% of female inhabitants belong-
ing to the screening target group reported to have had
at least one Pap smear in the last three years.20
Conversely, NADCs have become progressively cru-
cial over the years. In both men and women, incidence
of NADCs surpassed ADCs in the mid-2000s, but in
men, the incidence has been particularly increasing
since 2005, driven by lung and anal cancers. Other
NADCs, such as female breast and colorectal cancers
in the AIDS population follow the pattern of the gen-
eral population. In São Paulo, coverage of the breast
cancer screening programme is about 80%.20
The increasing trend in lung cancer among men
is not surprising. According to the Brazilian Ministry
of Health, the prevalence of smoking among PLWHA
ranges from 50 to 70%,19 which is considerably higher
than that of the general population (14.9% in 2013 in
São Paulo).20 Recent data from the US revealed that
lung cancer has decreased more rapidly in PLWHA
than in the general population, though the authors
believe that this might result from a faster decline in
smoking prevalence in the first group.2 In São Paulo
there are no data suggesting changes in smoking
prevalence in this population. In line with our results,
lung cancer in PLWHA in Italy has increased in the
post-HAART era when compared to the pre-HAART
era.5 Previous studies have shown that higher inci-
dence of lung cancer in this population is mainly
attributable to tobacco smoking rather than other
cofactors.21 There is an ongoing debate on the effect-
iveness of screening for lung cancer, and until there is
enough evidence to adopt it, management of this
malignancy must focus on strategies to promote
tobacco cessation.
As for anal cancer in the male population with
AIDS, there is a clear increasing trend since 2002,
which is contrary to the drop observed in the general
population. Similar results have been reported in Italy
and the US, though in the US increasing trends in
anal cancer in the AIDS population have been identi-
fied as driving the upward trend in the general popu-
lation.2,5 Anal cancer has been strongly linked to
persistent HPV infection and tobacco smoking,22 and
the risk among PLWHA is as high as 37-fold when
compared to the general population.23 A multicentre
study in Brazil of 445 HIV-positive men, found a
65.6% prevalence of HPV DNA in anal swabs, with
40.7% detected as oncogenic HPV strains.24 In an
effort towards early detection of anal cancer and its
precursor lesions in PLWHA, the Brazilian Ministry
of Health has recommended since 2013 annual anal
Pap smears for patients who have receptive anal inter-
course, HPV infection history, or abnormal vulvar or
cervical histology.19 This strategy could lead to
changes in anal cancer burden in the high-risk popu-
lation in the future.25
Our findings are closer to that of industrialized
countries, probably due to two aspects: the charac-
teristics of the AIDS epidemic and the access to anti-
retroviral therapy. In São Paulo, AIDS is still more
prevalent in men, with homosexual exposure to HIV
representing an important mode of transmission.
However, male-to-female ratio of AIDS cases has dra-
matically fallen from 26:1 in 1985 to 2:1 in 2011.26
In the US and Western European countries, the popu-
lations of PLWHA have similar features, whereas in
sub-Saharan Africa, women are disproportionally
more affected by AIDS and heterosexual infection is
predominant.27 Concerning antiretroviral therapy, pro-
vided in Brazil since 1996, treatment is free of cost
to all patients in need. Thus, regardless of a patient’s
economic condition, treatment is universal.28
The analysis of crude rates by age groups highlights
that as patients age the risk for cancer increases, but the
risk is more pronounced for NADCs. Incidence of
NADCs peaks at older ages, a pattern observed for
most cancers in the general population. Polesel et al.,5
when assessing NADCs in PLWHA in Italy, concluded
that the strong changes in crude rates were driven by
the ageing of the AIDS population.5
As for limitations, this study is restricted to the
AIDS population and does not examine HIV-only
patients. Even though the city of São Paulo occasion-
ally provided notices regarding HIV infection, notifica-
tion has only recently become mandatory (in June
2014). Thus, data for HIV-only cases for the study
period are not precise and was therefore not analysed.
Information on clinical data, including CD4þ cell
count, viral load and antiretroviral therapy was not
assessed because it is not routinely collected by the
AIDS registry (SINAN).
The shorter coverage period of the PBCR-SP has
limited our analysis to the post-HAART era. It would
have been valuable to understand the risk for cancer in
this population before HAART became fully available.
Three main sources of cancer underestimation may
have occurred in our study. First, this study relies
on probabilistic record linkage itself. This method is
not error free and might have failed in the identification
of some of those PLWHA who had cancer in the study
period. To minimize this issue and improve our data
matching sensitivity, a multi-step process was carried
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out and clerical review was employed. Even so, some
degree of underestimation may have occurred.
Nevertheless, this strategy has also been employed to
estimate cancer incidence in PLWHA in other countries
and is the primary source of population-based data.
A second factor that could result in cancer under-
estimation is outmigration. Residents of São Paulo who
were diagnosed with AIDS and outmigrated later could
not be captured by our database linkage. There are no
data on the percentage of outmigration among AIDS
patients, but available information from a report
assessing incident cancer cases registered in São Paulo
revealed that 4% of deaths were registered outside the
municipality (outmigration).29 If one assumes that the
percentage of AIDS cases that moved to other munici-
palities is similar and that not all of them would
develop cancer, then outmigration would not greatly
interfere with our findings.
Lastly, PLWHA who are unaware of their status
may have been misclassified in our study, and therefore
failed to contribute to the cancer burden in persons
with AIDS. Nevertheless, this is to be expected in stu-
dies, which are based on passive case finding.
Despite the aforementioned constraints, the present
study provides valuable population-based information
from a developing country. The current body of know-
ledge is composed mainly of research conducted in
developed countries with this study providing aggre-
gated data from a developing country known for its
particular plan to fight AIDS. Our findings highlight
a marked decrease in ADCs for both genders and a
recent increase in NADCs among men, mainly driven
by lung and anal cancers. Stratification by gender was
important to identify different patterns in cancer trends.
This suggests that exposure to risk factors for cancer,
such as smoking, varies according to gender and has to
be accounted for in explanations of gender differences.
In addition, women tend to seek health care more fre-
quently than men do and this might have affected the
risk of cancer.30
Risk for cancer in persons with AIDS increases dra-
matically as they age, with a similar pattern seen in the
general population. Because PLWHA are living longer
and reaching older ages due to advances in disease
treatment, cancer in this population will remain an
important issue to be addressed. Strategies to promote
lifestyle changes to reduce or eliminate modifiable risk
factors such as tobacco smoking, as well as screening
and early cancer detection are key points for the man-
agement of cancer in PLWHA.
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Saúde. Departamento de DST AIDS e Hepatites Virais.
Critérios de definição de casos de AIDS em adultos e crian-
ças. Brasilia: Ministério da Saúde, 2004.
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